Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans U Scherer

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Rheumatology (Oxford, England)|January 18, 2020
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLELaura S van Dam, Zgjim Osmani, Sylvia W A Kamerling, et al.
Annals of the Rheumatic Diseases|August 25, 2017
B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of <i>N</i>-glycosylation sites during somatic hypermutationRochelle D Vergroesen, Linda M Slot, Lise Hafkenscheid, et al.
Rheumatology (Oxford, England)|October 17, 2015
Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosisKai Hang Yiu, Maarten K Ninaber, Lucia J Kroft, et al.
Annals of the Rheumatic Diseases|June 3, 2015
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritisPriscilla F Kerkman, Emeline Fabre, Ellen I H van der Voort, et al.
The Lancet. Rheumatology|January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohortsSophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Kidney International|April 3, 2018
Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCATineke Kraaij, Sylvia W A Kamerling, Laura S van Dam, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Anticentromere Antibody Levels and Isotypes and the Development of Systemic SclerosisNina M van Leeuwen, Maaike Boonstra, Jaap A Bakker, et al.
Journal of Autoimmunity|April 12, 2018
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosusTineke Kraaij, Sylvia W A Kamerling, Esther N M de Rooij, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Arthritis and Rheumatism|February 24, 2010
Glycan profiling of anti-citrullinated protein antibodies isolated from human serum and synovial fluidHans U Scherer, Diane van der Woude, Andreea Ioan-Facsinay, et al.
Rheumatology (Oxford, England)|January 18, 2020
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLELaura S van Dam, Zgjim Osmani, Sylvia W A Kamerling, et al.
Annals of the Rheumatic Diseases|August 25, 2017
B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of <i>N</i>-glycosylation sites during somatic hypermutationRochelle D Vergroesen, Linda M Slot, Lise Hafkenscheid, et al.
Rheumatology (Oxford, England)|October 17, 2015
Impact of pulmonary fibrosis and elevated pulmonary pressures on right ventricular function in patients with systemic sclerosisKai Hang Yiu, Maarten K Ninaber, Lucia J Kroft, et al.
Annals of the Rheumatic Diseases|June 3, 2015
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritisPriscilla F Kerkman, Emeline Fabre, Ellen I H van der Voort, et al.
The Lancet. Rheumatology|January 24, 2024
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohortsSophie I E Liem, Maaike Boonstra, Saskia le Cessie, et al.
Kidney International|April 3, 2018
Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCATineke Kraaij, Sylvia W A Kamerling, Laura S van Dam, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Anticentromere Antibody Levels and Isotypes and the Development of Systemic SclerosisNina M van Leeuwen, Maaike Boonstra, Jaap A Bakker, et al.
Journal of Autoimmunity|April 12, 2018
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosusTineke Kraaij, Sylvia W A Kamerling, Esther N M de Rooij, et al.
Pageof 5